Ozempic vs Wegovy: One Molecule — Two Brands. What to Choose in Ukraine?
Weight Management and Healthy Lifestyle Experts

Imagine this situation. You're reading about the weight loss revolution, see two names — Ozempic and Wegovy — and can't understand: are these competitors or the same thing? Here's what's interesting: it's the same molecule from the same manufacturer. Just in different "packages" for different purposes.
And here's the main question: if Wegovy was created specifically for weight loss, and only Ozempic is available in Ukraine — is it even worth considering? Spoiler: the results will surprise you.
Quick answer for those in a hurry
- Buy Ozempic in Ukraine — original Ozempic (semaglutide) FlexTouch from Novo Nordisk, doses 0.25 / 0.5 / 1.0 mg. Cold chain 2–8°C, verified serial number, delivery by Bolt/Glovo in 2 hours in Kyiv or Nova Poshta 1–2 days throughout Ukraine. Ozempic Price 2026 — from 8,500 ₴ per pen, free consultation with DOZA specialist before ordering.
Ozempic and Wegovy are the same semaglutide, developed by Danish company Novo Nordisk. Both products work as GLP-1 receptor agonists, mimicking the natural satiety hormone [3].
The difference is simple:
- Ozempic: doses 0.25, 0.5, 1.0, 2.0 mg. Officially approved for type 2 diabetes. Widely used off-label for weight loss
- Wegovy: doses 0.25–2.4 mg. Specifically developed for weight management in people with obesity or overweight
Efficacy? Wegovy at maximum 2.4 mg dose provides approximately 16.9% weight loss. Ozempic at 1.0 mg dose — about 14.9%. The difference exists, but it's smaller than it seems at first glance.
The situation in Ukraine: Wegovy is not officially available due to global shortage and supply restrictions from Novo Nordisk. Ozempic is available through DOZA and pharmacy networks. And honestly, for most people this is sufficient.
What are Ozempic and Wegovy actually?
Both products contain semaglutide — a synthetic analog of human GLP-1 hormone, 94% identical to natural. When you inject, the molecule binds to receptors in brain and pancreas. Result? You feel full faster, eat less, and blood sugar stabilizes.
Semaglutide 2.4 mg (Wegovy) is officially indicated for reducing risk of major cardiovascular events in patients with cardiovascular disease and obesity or overweight [1]. This is important: the product doesn't just help lose weight, but protects the heart.
Approval history:
- Ozempic: FDA approved in 2017 for type 2 diabetes
- Wegovy: FDA approved in 2021 specifically for chronic weight management
One manufacturer — Novo Nordisk. One molecule — semaglutide. The difference is in maximum dose and official indications. If you want to understand the mechanism of action of semaglutide more deeply, I recommend reading our article about the GLP-1 molecule.
Уявіть семаглутід як ключ, який підходить до замка апетиту у вашому мозку. І Оземпік (Ozempic), і Вегові (Wegovy) — це той самий ключ. Просто Вегові (Wegovy) робить більше "обертів", бо доза вища.

Summary table of differences: Ozempic vs Wegovy
Порівняння Ozempic та Wegovy
| Параметр | Ozempic (Оземпік) | Wegovy (Вегові) |
|---|---|---|
| Діюча речовина | Семаглутід | Семаглутід |
| Виробник | Novo Nordisk | Novo Nordisk |
| Максимальна доза | 2.0 мг | 2.4 мг |
| Офіційне показання | Діабет 2 типу | Ожиріння / надлишкова вага |
| Втрата ваги | ~14.9% | ~16.9% |
| Кардіопротекція | Теоретично так | Доведено в SELECT |
| Доступність в Україні | Доступний | Недоступний |
| Ціна в DOZA | Від 6 500 грн | — |
As you can see, Wegovy formally wins on several parameters. But there's one critical "but": it's simply not available in Ukraine. And the efficacy difference between 14.9% and 16.9% weight loss — that's approximately 2 kg per 100 kg initial weight. For most people this is not a determining factor.
Cardioprotection — semaglutide's unique advantage
This is where semaglutide truly stands out among other weight loss products. The SELECT study demonstrated 20% reduction in risk of major cardiovascular events (heart attack, stroke, death) in patients with obesity and cardiovascular disease [5].
This isn't just weight loss. This is heart protection. And most interestingly — semaglutide's cardioprotective effect doesn't depend entirely on degree of weight loss [5]. In other words, the molecule protects the heart through additional mechanisms: anti-inflammatory action, improved endothelial function, blood pressure and lipid profile stabilization.
In the SELECT study participants were observed for average 3.5 years (41.8 months). All received semaglutide 2.4 mg or placebo along with standard therapy (blood pressure, cholesterol medications) and healthy lifestyle counseling [1].
STEER study results showed even more impressive data: semaglutide 2.4 mg reduced risk of 3-component MACE (heart attack, stroke, death from any cause) by 57% compared to tirzepatide [4].

Is Ozempic sufficient for effective weight loss?
Short answer: yes, for most people — sufficient.
Let's look at the numbers:
- Ozempic 1.0 mg provides about 14.9% weight loss
- At initial weight 90 kg this is approximately 13.4 kg
- At 100 kg — nearly 15 kg
These aren't just numbers on scales. This is a different clothing size. This is ease climbing stairs. This is better blood tests. This is reduced risk of diabetes and cardiovascular disease.
On our real results page you can see photos and stories of DOZA clients who completed the program with Ozempic.
Спеціаліст DOZA допоможе обрати оптимальний продукт та дозу за 5 хвилин
Консультація з підбору програмиWhich product to choose? Depends on your goals and budget:
- Ozempic — if you need a budget option with proven effectiveness. View catalog
- Mounjaro — if the goal is maximum results and budget allows. View catalog
- Wegovy — theoretically best for cardioprotection, but unavailable in Ukraine
If you're still hesitating what to choose — I recommend reading detailed comparison of Ozempic and Mounjaro or taking quick quiz for program selection.
Для більшості клієнтів ми рекомендуємо починати з Мунджаро (Mounjaro) якщо бюджет дозволяє — він дає швидший та більш виражений результат. Оземпік (Ozempic) — відмінна альтернатива для тих хто шукає економніший варіант.

What happens week by week?
Many clients ask: how quickly will I feel changes? Here's a typical scenario for semaglutide:
Week 1–2: You notice eating smaller portions. Satiety comes faster. This isn't discomfort — you simply forget about food between meals.
Week 3–4: Weight starts declining. Usually 2–4 kg in first month. More energy because body doesn't spend energy digesting large portions.
Month 2–3: Results become noticeable to others. Clothes fit looser. Most side effects (if any) disappear.
Month 4–6: You reach stable pace of 0.5–1 kg loss per week. New eating habits form.
Detailed Ozempic dosing instructions will help you increase the dose correctly.
Кожна людина унікальна. Темп схуднення залежить від початкової ваги, метаболізму, харчових звичок. Не порівнюйте себе з іншими — порівнюйте себе з собою вчорашнім.

Final thoughts
Ozempic and Wegovy are the same molecule. Difference in dose and official indications. Only Ozempic is available in Ukraine, and it's a perfectly sufficient option for effective weight loss.
14.9% weight loss on Ozempic is a serious result. For a person weighing 90 kg this is more than 13 kg. Plus potential heart protection that semaglutide provides regardless of weight loss degree.
If you want maximum results — Mounjaro gives up to 22.5% and is available at DOZA. If you're looking for a more economical option — Ozempic from 6,500 hrn will do its job.
We're here to help you figure out what's right for you. Write to us on Telegram @Doza_sofia_bot — first consultation is free and without obligations.
Where to buy
DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:
- Buy Mounjaro in Ukraine — DOZA catalog with all 6 doses (2.5–15 mg) and official 24h cold-chain delivery. Current Mounjaro prices.
FAQ

📚 Sources & references
- 1Wegovy® for Cardiovascular Risk | Wegovy® (semaglutide)
Дані про дослідження SELECT: 3.5 роки спостереження, зниження ризику серцево-судинних подій у пацієнтів з ожирінням
- 2Wegovy® (semaglutide) and CV Risk Reduction | Novo Nordisk
Детальний опис дизайну дослідження SELECT: 17 604 учасника, рандомізація 1:1, 16-тижнева ескалація дози
- 3Semaglutide 2.4 mg Clinical Outcomes: A Real-World Study | PMC
Дані про ефективність семаглутіду 2.4 мг: 13.3% зниження ваги у STEP-HFpEF, показання FDA для зниження кардіоваскулярного ризику
- 4Semaglutide Superior to Tirzepatide in Reducing CV Event Risk | Cardiology Advisor
Результати дослідження STEER: семаглутід 2.4 мг знизив ризик MACE на 57% порівняно з тирзепатидом
- 5Semaglutide lowers cardiovascular events even without major weight loss | News Medical
Аналіз SELECT: 20% зниження MACE, кардіопротективний ефект не залежить від ступеня втрати ваги
❓ FAQ
Technically yes, as it's the same semaglutide molecule. But Wegovy is unavailable in Ukraine, so switching is not relevant. If you need a stronger effect, DOZA specialists recommend considering Mounjaro with dual mechanism of action.
Anastasia Shapoval
Metabolic Programs and Weight Control Specialist
Article author
DOZA TeamWeight Management and Healthy Lifestyle Experts
The DOZA team of specialists with years of experience in personalized weight loss programs with Mounjaro. Every article is reviewed by experts and based on current scientific research.
About DOZA
DOZA is Ukraine's leading online medical weight-loss support service based on tirzepatide (Mounjaro) and GLP-1. Operating since 2023, 2,147+ clients, 24/7 specialist support, cold chain delivery across Ukraine.
The materials in this article are for informational purposes only. Please consult a specialist before starting any weight management program. For a free consultation message us on Telegram.
Ozempic in Ukraine
Original semaglutide by Novo Nordisk — with delivery and 24/7 specialist support
Ready to start?
Message us — a specialist will select a program for you in 5 minutes. Free of charge.
💬 Message on TelegramFree consultation • We respond 24/7